These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1132 related items for PubMed ID: 18044336

  • 21. Analysis of Borrelia burgdorferi IgG antibodies with a combination of IgG ELISA and VlsE C6 peptide ELISA.
    Jansson C, Carlsson SA, Granlund H, Wahlberg P, Nyman D.
    Clin Microbiol Infect; 2005 Feb; 11(2):147-50. PubMed ID: 15679490
    [Abstract] [Full Text] [Related]

  • 22. [Comparison of EIA Borrelia recombinant IgM of the 3rd generation with EIA test based on whole cell antigen in the diagnosis of Lyme borreliosis].
    Krbková L, Stroblová H.
    Klin Mikrobiol Infekc Lek; 2004 Dec; 10(6):271-8. PubMed ID: 15655723
    [Abstract] [Full Text] [Related]

  • 23. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G, Breier F, Menzinger G, Schaar B, Hafner M, Partsch H.
    Wien Klin Wochenschr; 1999 Dec 10; 111(22-23):951-6. PubMed ID: 10666807
    [Abstract] [Full Text] [Related]

  • 24. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
    Branda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ.
    Clin Infect Dis; 2011 Sep 10; 53(6):541-7. PubMed ID: 21865190
    [Abstract] [Full Text] [Related]

  • 25. [Antibodies against Borrelia afzelli in patients with an early stage of Lyme disease].
    Flisiak I, Chodynicka B.
    Wiad Lek; 2001 Sep 10; 54(1-2):19-25. PubMed ID: 11344697
    [Abstract] [Full Text] [Related]

  • 26. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M, Zomer TP, van Kooten B, Blaauw G, van Bemmel T, van Hees BC, Vermeeren YM, Landman GW.
    Ticks Tick Borne Dis; 2018 Mar 10; 9(3):594-597. PubMed ID: 29422448
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods.
    Tylewska-Wierzbanowska S, Chmielewski T.
    Wien Klin Wochenschr; 2002 Jul 31; 114(13-14):601-5. PubMed ID: 12422608
    [Abstract] [Full Text] [Related]

  • 29. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
    Dickeson DJ, Chen SC, Sintchenko VG.
    Pathology; 2016 Apr 31; 48(3):251-6. PubMed ID: 27020501
    [Abstract] [Full Text] [Related]

  • 30. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.
    Wilske B, Fingerle V, Herzer P, Hofmann A, Lehnert G, Peters H, Pfister HW, Preac-Mursic V, Soutschek E, Weber K.
    Med Microbiol Immunol; 1993 Nov 31; 182(5):255-70. PubMed ID: 8283961
    [Abstract] [Full Text] [Related]

  • 31. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
    Bradshaw GL, Thueson RK, Uriona TJ.
    J Clin Microbiol; 2017 Oct 31; 55(10):3046-3056. PubMed ID: 28768731
    [Abstract] [Full Text] [Related]

  • 32. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide.
    Panelius J, Lahdenne P, Saxén H, Carlsson SA, Heikkilä T, Peltomaa M, Lauhio A, Seppälä I.
    J Neurol; 2003 Nov 31; 250(11):1318-27. PubMed ID: 14648148
    [Abstract] [Full Text] [Related]

  • 33. Comparison of five different immunoassays for the detection of Borrelia burgdorferi IgM and IgG antibodies.
    Smismans A, Goossens VJ, Nulens E, Bruggeman CA.
    Clin Microbiol Infect; 2006 Jul 31; 12(7):648-55. PubMed ID: 16774561
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens.
    Magnarelli LA, Ijdo JW, Padula SJ, Flavell RA, Fikrig E.
    J Clin Microbiol; 2000 May 31; 38(5):1735-9. PubMed ID: 10790090
    [Abstract] [Full Text] [Related]

  • 37. Persistent Anti-Borrelia IgM Antibodies without Lyme Borreliosis in the Clinical and Immunological Context.
    Markowicz M, Reiter M, Gamper J, Stanek G, Stockinger H.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0102021. PubMed ID: 34937165
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of the C6 enzyme-linked immunoadsorbent assay for the serodiagnosis of Lyme borreliosis in north-eastern Italy.
    Cinco M, Murgia R.
    New Microbiol; 2006 Apr 22; 29(2):139-41. PubMed ID: 16841555
    [Abstract] [Full Text] [Related]

  • 39. [Criteria for evaluation of immunoblots using Borrelia afzelii, Borrelia garinii and Borrelia burgdorferi sensu stricto for diagnosis of Lyme borreliosis].
    Honegr K, Havlasová J, Gebouský P, Dostál V, Pellantová V, Skrabková Z, Hulínská D.
    Epidemiol Mikrobiol Imunol; 2001 Nov 22; 50(4):147-56. PubMed ID: 11769176
    [Abstract] [Full Text] [Related]

  • 40. The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.
    Peltomaa M, McHugh G, Steere AC.
    Otol Neurotol; 2004 Sep 22; 25(5):838-41. PubMed ID: 15354020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.